Patents by Inventor Siyi Pan

Siyi Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230389566
    Abstract: The present disclosure provides a multicolored hawthorn polyphenol low-sugar soft sweet, comprising the following raw materials: 58 g to 62 g of a hawthorn puree, 6 g to 8 g of xylitol, 4 mg to 5 mg of hawthorn polyphenol, 5.0 g±0.5 g of gelatin, 0.3 g±0.1 g of agar, and a hawthorn fruit vinegar powder, the hawthorn fruit vinegar powder is added to allow a sugar-acid ratio of the multicolored hawthorn polyphenol low-sugar soft sweet to be (27-30):1.
    Type: Application
    Filed: September 26, 2022
    Publication date: December 7, 2023
    Inventors: Suwen Liu, Xinfang Wang, Xuedong Chang, Runfeng Li, Siyi Pan
  • Patent number: 11751591
    Abstract: A strain of Oceanobacillus picturae and applications thereof are provided, which relate to technical fields of microorganism and food processing. A strain of halophilic bacteria was screened from the brine of Xiangyang Pickled Kohlrabi and was identified as the strain of Oceanobacillus picturae by morphology, physical and chemical properties and 16S rRNA sequence. The strain is able to significantly increase the varieties and contents of volatile substances, and decrease the contents of pungent substances in pickled vegetables. The strain of Oceanobacillus picturae can improve the taste and the flavor of the pickled vegetables.
    Type: Grant
    Filed: September 5, 2020
    Date of Patent: September 12, 2023
    Assignee: Hunzhong Agricultural University
    Inventors: Xiaoyun Xu, Ting Wu, Jie Song, Siyi Pan
  • Publication number: 20210236451
    Abstract: 1,4-dicaffeoylquinic acid is used as a xanthine oxidase inhibitor and in preparation of a medicament for treating gout. The present invention is the first to isolate and identify five dicaffeoylquinic acid compounds from Artemisia selengensis leaves. The compound not only has an ability of inhibiting xanthine oxidase activity, but also has the function of anti-gout inflammation, which can be better used for treating gout. The dicaffeoylquinic acid is derived from natural plants and has the advantages of being safe and non-toxic, and having fewer side effects.
    Type: Application
    Filed: April 20, 2021
    Publication date: August 5, 2021
    Inventors: Xiaoyun Xu, Weiwei Cao, Ting Wu, Siyi Pan
  • Patent number: 11020367
    Abstract: 1,4-dicaffeoylquinic acid is used as a xanthine oxidase inhibitor and in preparation of a medicament for treating gout. The present invention is the first to isolate and identify a dicaffeoylquinic acid compound from Artemisia selengensis leaves. The compound not only has an ability of inhibiting xanthine oxidase activity, but also has the function of anti-gout inflammation, which can be better used for treating gout. The dicaffeoylquinic acid is derived from natural plants and has the advantages of being safe and non-toxic, and having fewer side effects.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: June 1, 2021
    Assignee: Huazhong Agricultural University
    Inventors: Xiaoyun Xu, Ting Wu, Weiwei Cao, Siyi Pan, Hui Li
  • Publication number: 20200397027
    Abstract: A strain of Oceanobacillus picturae and applications thereof are provided, which relate to technical fields of microorganism and food processing. A strain of halophilic bacteria was screened from the brine of Xiangyang Pickled Kohlrabi and was identified as the strain of Oceanobacillus picturae by morphology, physical and chemical properties and 16S rRNA sequence. The strain is able to significantly increase the varieties and contents of volatile substances, and decrease the contents of pungent substances in pickled vegetables. The strain of Oceanobacillus picturae can improve the to taste and the flavor of the pickled vegetables.
    Type: Application
    Filed: September 5, 2020
    Publication date: December 24, 2020
    Inventors: Xiaoyun Xu, Ting Wu, Jie Song, Siyi Pan
  • Publication number: 20200000761
    Abstract: 1,4-dicaffeoylquinic acid is used as a xanthine oxidase inhibitor and in preparation of a medicament for treating gout. The present invention is the first to isolate and identify a dicaffeoylquinic acid compound from Artemisia selengensis leaves. The compound not only has an ability of inhibiting xanthine oxidase activity, but also has the function of anti-gout inflammation, which can be better used for treating gout. The dicaffeoylquinic acid is derived from natural plants and has the advantages of being safe and non-toxic, and having fewer side effects.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 2, 2020
    Inventors: Xiaoyun Xu, Ting Wu, Weiwei Cao, Siyi Pan, Hui Li